Condition

Infantile myofibromatosis

Neoplasms

Infantile myofibromatosis is a rare disorder in which one or more noncancerous tumors grow in the skin, bone, muscle and soft tissue, and only rarely in the internal organs. The tumors do not spread to distant sites, but they can grow large enough to press on or damage nearby structures, and a form that involves the internal organs can be life-threatening. Most cases begin in infancy or early childhood, although adult-onset cases are described. The solitary form is the most common and tends to affect males, while the multiple forms are more common in females. Most cases arise without any known cause and without a family history, but rare families carry variants in the PDGFRB or NOTCH3 genes. The disorder was first described as a distinct entity in 1954 by Arthur Purdy Stout, who called it congenital generalized fibromatosis, and the name infantile myofibromatosis was introduced in 1981. Its incidence is estimated at between 1 in 150,000 and 1 in 400,000 live births. Many tumors regress on their own, surgery is the main option for focal tumors, and chemotherapy is reserved for cases that involve the internal organs and cannot be treated surgically. This entry records what the sources state and is not medical advice.

Facts
Classification
Body System
Integumentary System 1
Body System
Skeletal System 1
Body System
Muscular System 1
Communicable or Non-communicable
Non-Communicable 1
Transmission Route
Non-Transmissible 1
First Described
1954 1
Prevalence
1 in 150,000 to 1 in 400,000 live births 2
Prevalence Band
Rare (Under 1 in 2000) 1
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Connections

Discovered By

Source Infantile Myofibromatosis (NORD)

Treats

Source Infantile Myofibromatosis (NORD)
Sources
1. Infantile Myofibromatosis (NORD)
  • Disease Overview, bone
    the growth of one or more noncancerous (benign) tumors affecting the skin, bone, muscle, soft tissue and rarely the internal organs (viscera)
  • Disease Overview, muscle
    the growth of one or more noncancerous (benign) tumors affecting the skin, bone, muscle, soft tissue and rarely the internal organs (viscera)
  • Causes
    variants in two genes have been identified as causing the disorder in some people
  • Causes, genetic and familial cases
    Rare cases of myofibromatosis have been identified that run in families
  • Causes, inherited not infectious
    Most cases of infantile myofibromatosis occur randomly, for no apparent reason.
  • Introduction
    Infantile myofibromatosis was first described as a distinct entity in the medical literature in 1954 by Dr. A.P. Stout.
  • Affected populations
    estimated to be between 1 in 150,000 to 400,000 live births
  • Discovered By: Arthur Purdy Stout, Introduction, first description
    Infantile myofibromatosis was first described as a distinct entity in the medical literature in 1954 by Dr. A.P. Stout.
  • Treats: Chemotherapy, Standard Therapies, chemotherapy
    Chemotherapy may be used to treat cases where there is involvement of the internal organs and surgery was unsuccessful
View the Source
2. Infantile myofibromatosis (Wikipedia)
Lead, incidence
Quote, Lead, incidence
Infantile myofibromatosis (IMF) is a rare tumor found in 1 in 150,000 to 1 in 400,000 live births.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme